Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Co-PSMA trial: Recruitment successfully completed 2025-07-17 21:01
High-Trend International Group Held Extraordinary General Meeting for Share Capital Restructure 2025-07-17 21:00
Jay Chou Joins Douyin, Leading a New Wave of Chinese Pop Culture 2025-07-17 20:40
Recurrent Energy Secures $260 Million Financing for Blue Moon Solar Project in Kentucky 2025-07-17 19:00
SK bioscience Submits IND for Phase 1/2 Clinical Trial of Adjuvanted Influenza Vaccine Candidate 2025-07-17 19:00
GC Biopharma Receives Marketing Authorization for BARYCELA in Vietnam 2025-07-17 13:56
Nature Medicine Published Phase 1 Results of Innovent Biologics' Anti-CLDN18.2 ADC (IBI343) in Patients with Advanced Gastric/Gastroesophageal Junction Adenocarcinoma 2025-07-17 08:00
Health In Tech Supports Foster Closet to Help Children and Families in Need 2025-07-17 04:30
B2B Rocket joins publicly traded tech powerhouse in move to scale smarter and faster 2025-07-17 02:10
TROOPS, Inc. (NASDAQ: TROO) Subsidiary Enters Letter of Intent to Acquire Stake in Malaysian Co-living and Co-working Space 2025-07-16 23:00
UAE Investment Institution Acquires Strategic Stake in NWTN to Advance "We the UAE 2031" Vision 2025-07-16 22:05
Samyang Corporation Unveils 'AI-Based Standardized Sugar Reduction Solution' at US Food Technology Expo 2025-07-16 20:30
AUTOCRYPT Announces Successful KOSDAQ Listing 2025-07-16 20:00
WuXi Biologics Granted Highest Negligible-Risk ESG Rating from Morningstar Sustainalytics 2025-07-16 18:00
Yum China to Report Second Quarter 2025 Financial Results 2025-07-16 17:00
LG BRINGS PREMIUM STREAMING TO NEW KIA MODELS IN EUROPE WITH WEBOS AUTOMOTIVE CONTENT PLATFORM 2025-07-16 14:00
Zeekr Group to Report Second Quarter 2025 Financial Results on August 14, 2025 2025-07-16 13:00
Senhwa Biosciences announces first patient dosed in NCI-sponsored pilot study of Pidnarulex (CX-5461) pharmacodynamics in patients with advanced solid tumors 2025-07-16 10:32
Akeso Announces First Patient Enrolled in the Phase III Trial(AK112-312/HARMONi-GI6)of Ivonescimab for First-Line Treatment of Advanced Metastatic Colorectal Cancer 2025-07-16 09:47
Fly-E Group, Inc. Announces Fiscal Year 2025 Financial Results 2025-07-16 08:00